{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:54:58Z","timestamp":1771037698633,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00784-018-2444-8","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T17:04:15Z","timestamp":1524071055000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-536X","authenticated-orcid":false,"given":"Adrian","family":"M\u00fcnscher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Prochnow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"L\u00f6rincz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Blessmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Hanken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till Sebastian","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"issue":"2","key":"2444_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrc1549","volume":"5","author":"KD Hunter","year":"2005","unstructured":"Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5(2):127\u2013135","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2444_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ijc.2910410205","volume":"41","author":"DM Parkin","year":"1988","unstructured":"Parkin DM, L\u04d3\u04d3r\u04d3 E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41(2):184\u2013197","journal-title":"Int J Cancer"},{"issue":"2","key":"2444_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/154405910708600202","volume":"86","author":"CC Ragin","year":"2007","unstructured":"Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86(2):104\u2013114","journal-title":"J Dent Res"},{"issue":"8","key":"2444_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/hed.20059","volume":"26","author":"H Sharma","year":"2004","unstructured":"Sharma H, Sen S, Mathur M, Bahadur S, Singh N (2004) Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 26(8):733\u2013740","journal-title":"Head Neck"},{"issue":"6","key":"2444_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.oooo.2014.02.005","volume":"117","author":"A Pickhard","year":"2014","unstructured":"Pickhard A, Gr\u04e7ber S, Haug AK et al (2014) Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):733\u2013742","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"8","key":"2444_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/ijc.28200","volume":"133","author":"L Farnebo","year":"2013","unstructured":"Farnebo L, Tiefenb\u04e7ck K, Ansell A, Thunell LK, Garvin S, Roberg K (2013) Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. Int J Cancer 133(8):1994\u20132003","journal-title":"Int J Cancer"},{"issue":"6","key":"2444_CR7","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ijc.22941","volume":"121","author":"BM Lippert","year":"2007","unstructured":"Lippert BM, Knauer SK, Fetz V, Mann W, Stauber RH (2007) Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer 121(6):1169\u20131174","journal-title":"Int J Cancer"},{"issue":"8","key":"2444_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917\u2013921","journal-title":"Nat Med"},{"issue":"1","key":"2444_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/00016480902856588","volume":"130","author":"G Marioni","year":"2010","unstructured":"Marioni G, D\u2019Alessandro E, Bertolin A, Staffieri A (2010) Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges. Acta Otolaryngol 130(1):4\u20139","journal-title":"Acta Otolaryngol"},{"issue":"7","key":"2444_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijom.2007.04.003","volume":"36","author":"MA Scheper","year":"2007","unstructured":"Scheper MA, Nikitakis NG, Sauk JJ (2007) Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Int J Oral Maxillofac Surg 36(7):632\u2013639","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"2444_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.juro.2015.02.036","volume":"194","author":"M Cui","year":"2015","unstructured":"Cui M, Au JL, Wientjes MG, O\u2019Donnell MA, Loughlin KR, Lu Z (2015) Intravenous siRNA silencing of survivin enhances activity of mitomycin C in human bladder RT4 xenografts. J Urol 194(1):230\u2013237","journal-title":"J Urol"},{"key":"2444_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12885-015-1441-4","volume":"15","author":"JA Gibbons","year":"2015","unstructured":"Gibbons JA, Kanwar JR, Kanwar RK (2015) Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15:425","journal-title":"BMC Cancer"},{"issue":"6","key":"2444_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.acthis.2015.05.006","volume":"117","author":"M Adamkov","year":"2015","unstructured":"Adamkov M, V\u00fdbohov\u00e1 D, Tup\u00e1 V, Chyl\u00edkov\u00e1 J, Hor\u00e1\u010dek J, Ben\u010dat M (2015) Expression and significance of survivin in colorectal high grade and low grade adenomas. Acta Histochem 117(6):590\u2013594","journal-title":"Acta Histochem"},{"issue":"16","key":"2444_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/onc.2015.271","volume":"35","author":"P Phatak","year":"2016","unstructured":"Phatak P, Byrnes KA, Mansour D, Liu L, Cao S, Li R, Rao JN, Turner DJ, Wang JY, Donahue JM (2016) Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1. Oncogene 35(16):2087\u20132097","journal-title":"Oncogene"},{"issue":"9","key":"2444_CR15","first-page":"1808","volume":"58","author":"CD Lu","year":"1998","unstructured":"Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58(9):1808\u20131812","journal-title":"Cancer Res"},{"issue":"16","key":"2444_CR16","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1158\/1078-0432.CCR-10-0076","volume":"16","author":"T Ezponda","year":"2010","unstructured":"Ezponda T, Pajares MJ, Agorreta J, Echeveste JI, Lopez-Picazo JM, Torre W, Pio R, Montuenga LM (2010) The oncoprotein SF2\/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clin Cancer Res 16(16):4113\u20134125","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2444_CR17","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1158\/1078-0432.CCR-06-0571","volume":"12","author":"KW Yip","year":"2006","unstructured":"Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O\u2019Sullivan B, Bastianutto C, Liu FF (2006) Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 12(19):5726\u20135732","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2444_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3892\/mmr.2015.3380","volume":"12","author":"XP Yi","year":"2015","unstructured":"Yi XP, Han T, Li YX, Long XY, Li WZ (2015) Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN\/PI3K\/Akt pathway. Mol Med Rep 12(1):601\u2013608","journal-title":"Mol Med Rep"},{"issue":"7","key":"2444_CR19","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1021\/acs.biomac.5b00562","volume":"16","author":"F Cavalieri","year":"2015","unstructured":"Cavalieri F, Beretta GL, Cui J, Braunger JA, Yan Y, Richardson JJ, Tinelli S, Folini M, Zaffaroni N, Caruso F (2015) Redox-sensitive PEG-polypeptide nanoporous particles for survivin silencing in prostate cancer cells. Biomacromolecules 16(7):2168\u20132178","journal-title":"Biomacromolecules"},{"issue":"3","key":"2444_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1600-0463.2008.00003.x","volume":"117","author":"CK Lin","year":"2009","unstructured":"Lin CK, Chao TK, Yu CP, Yu MH, Jin JS (2009) The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. APMIS 117(3):162\u2013175","journal-title":"APMIS"},{"issue":"6","key":"2444_CR21","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1158\/1078-0432.CCR-06-2129","volume":"13","author":"AE Krambeck","year":"2007","unstructured":"Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED (2007) Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clin Cancer Res 13(6):1749\u20131756","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2444_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jocd.12150","volume":"14","author":"F Labarrade","year":"2015","unstructured":"Labarrade F, Bergeron L, Serre C, Lebleu A, Busuttil V, Botto JM, Domloge N (2015) Modulating the expression of survivin and other basal epidermal proteins protects human skin from UVB damage and oxidative stress. J Cosmet Dermatol 14(3):191\u2013203","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"2444_CR23","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/1535-7163.MCT-05-0375","volume":"5","author":"S Fukuda","year":"2006","unstructured":"Fukuda S, Pelus LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5):1087\u20131098","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"2444_CR24","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/S0959-8049(02)00247-2","volume":"38","author":"T Yamamoto","year":"2002","unstructured":"Yamamoto T, Manome Y, Nakamura M, Tanigawa N (2002) Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur J Cancer 38(17):2316\u20132324","journal-title":"Eur J Cancer"},{"issue":"2","key":"2444_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.radonc.2010.06.005","volume":"96","author":"Z Khan","year":"2010","unstructured":"Khan Z, Khan N, Tiwari RP, Patro IK, Prasad GB, Bisen PS (2010) Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells. Radiother Oncol 96(2):267\u2013273","journal-title":"Radiother Oncol"},{"issue":"8","key":"2444_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hed.21071","volume":"31","author":"Z Khan","year":"2009","unstructured":"Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GBKS, Shrivastava BR, Bisen PS (2009) Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck 31(8):1039\u20131048","journal-title":"Head Neck"},{"issue":"16","key":"2444_CR27","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","volume":"14","author":"AC Mita","year":"2008","unstructured":"Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008) Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14(16):5000\u20135005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2444_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0971-5916.159250","volume":"141","author":"PK Jaiswal","year":"2015","unstructured":"Jaiswal PK, Goel A, Mittal RD (2015) Survivin: a molecular biomarker in cancer. Indian J Med Res 141(4):389\u2013397","journal-title":"Indian J Med Res"},{"issue":"7","key":"2444_CR29","first-page":"537","volume":"83","author":"J Walig\u00f3rska-Stachura","year":"2012","unstructured":"Walig\u00f3rska-Stachura J, Jankowska A, Wa\u015bko R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-B\u0142aszyk D, Shimek V, Rucha\u0142a M (2012) Survivin\u2014prognostic tumor biomarker in human neoplasms\u2014review. Ginekol Pol 83(7):537\u2013540","journal-title":"Ginekol Pol"},{"issue":"4","key":"2444_CR30","first-page":"803","volume":"59","author":"L Bubendorf","year":"1999","unstructured":"Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59(4):803\u2013806","journal-title":"Cancer Res"},{"issue":"4\u20135","key":"2444_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4\u20135):309\u2013316","journal-title":"Oral Oncol"},{"issue":"2","key":"2444_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2444_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.0959-9673.2005.00447.x","volume":"86","author":"GR Thomas","year":"2005","unstructured":"Thomas GR, Nadiminti H, Regalado J (2005) Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86(6):347\u2013363","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"2444_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/hed.10004","volume":"24","author":"GF Funk","year":"2002","unstructured":"Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT (2002) Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24(2):165\u2013180","journal-title":"Head Neck"},{"issue":"5B","key":"2444_CR35","first-page":"3813","volume":"26","author":"G Marioni","year":"2006","unstructured":"Marioni G, Bertolin A, Giacomelli L, Marchese-Ragona R, Savastano M, Calgaro N, Marino F, de Filippis C, Staffieri A (2006) Expression of the apoptosis inhibitor protein survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res 26(5B):3813\u20133817","journal-title":"Anticancer Res"},{"issue":"2","key":"2444_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.radonc.2015.12.007","volume":"118","author":"Z Khan","year":"2016","unstructured":"Khan Z, Khan AA, Prasad G, Khan N, Tiwari RP, Bisen PS (2016) Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus. Radiother Oncol 118(2):359\u2013368","journal-title":"Radiother Oncol"},{"issue":"9","key":"2444_CR37","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","volume":"80","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80(9):1803\u20131804","journal-title":"Cancer"},{"key":"2444_CR38","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1038\/cddis.2015.139","volume":"6","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang W, Wang Y-F, Liu B, Zhang WF, Zhao YF, Kulkarni AB, Sun ZJ (2015) Dual induction of apoptotic and autophagic cell death by targeting survivin in head and neck squamous cell carcinoma. Cell Death Dis 6:e1771","journal-title":"Cell Death Dis"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-018-2444-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2444-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T06:58:35Z","timestamp":1567061915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-018-2444-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1007\/s00784-018-2444-8","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}